References

Question 1

Conn PJ et al (2009)

Answer 1

Allosteric Modulation of GPCRs:

E.G Used to increase selectivity of activation of mAchR subtypes

Question 2

Rajagopal S et al (2010).

Answer 2

Biased Ligands

Question 3

DeWire SM et al (2011)

Answer 3

Biased Ligands paper that highlights the examples with arrestins

Question 4

Mansoor AH et al (2009)

Answer 4

Adrenergic Receptors:

Beta blocker generations and indication

Question 5

Robinson E et al (1998)

Answer 5

Different types of adrenergic receptors paper

Question 6

Zoli M et al (2014)

Answer 6

Nicotinic Receptors

Question 7

Matera C et al (2014)

Answer 7

Muscarinic Receptors

Question 8

Hanahan D and Weinberg RA (2011)

Answer 8

Hallmarks of cancer, next generation

Question 9

Lind MJ (2011)

Answer 9

Cytotoxic cancer therapies

Question 10

Abraham J et al (2011)

Answer 10

Hormone therapies for cancers

Question 11

Corrie PG (2011)

Answer 11

Cytotoxic chemotherapy

Question 12

Pardoll DM (2012)

Answer 12

Blockade of immune checkpoints

Question 13

Probstfield JL (2010)

Answer 13

RAAS overview

Question 14

Elliott WJ et al (2011)

Answer 14

Calcium Channel blockers

Question 15

Hanahan D and Weinberg RA (2000)

Answer 15

Original hallmarks of cancer paper